MPO and colitis: Prevention of the DSS-induced increase in MPO concentrations indicates that Frondanol prevents the accumulation of polymorphonuclear granulocytes in DSS-induced colitis tissue, since MPO activity reflects the increase in neutrophil accumulation in the submucosa due to the severity of colitis [24].